b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1550829/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Clinical review: A systematic review of corticosteroid use in infections</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550829/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Critical Care" /><meta name="citation_title" content="Clinical review: A systematic review of corticosteroid use in infections" /><meta name="citation_authors" content="Jody Aberdein, Mervyn Singer" /><meta name="citation_date" content="2005" /><meta name="citation_volume" content="10" /><meta name="citation_doi" content="10.1186/cc3904" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1550829/?report=abstract" /><meta name="citation_pmid" content="16356204" /><meta name="DC.Title" content="Clinical review: A systematic review of corticosteroid use in infections" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Jody Aberdein" /><meta name="DC.Contributor" content="Mervyn Singer" /><meta name="DC.Date" content="2005" /><meta name="DC.Identifier" content="10.1186/cc3904" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Clinical review: A systematic review of corticosteroid use in infections" /><meta property="og:type" content="article" /><meta property="og:description" content="Traditional teaching suggests that corticosteroids should be avoided during acute infectious episodes for fear of compromising the immune response. However, the outcome benefit shown through steroid administration in early septic shock implies this paranoia ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550829/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1550829/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1550829/pdf/13054_2005_Article_3820.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1BD914E99A95210000000002280228.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC1550829</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">Critical Care</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Crit Care</span>. 2005; 10: 203. </span></div><div><span class="fm-vol-iss-date">Published online 2005 Nov 22. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2Fcc3904" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/cc3904</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1550829</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/16356204">16356204</a></div></div></div></div><h1 class="content-title">Clinical review: A systematic review of corticosteroid use in infections</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Aberdein%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16356204" class="affpopup" co-rid="_co_idm139732525844768" co-class="co-affbox">Jody Aberdein</a><sup>1</sup> and  <a href="/pubmed/?term=Singer%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16356204" class="affpopup" co-rid="_co_idm139732524678928" co-class="co-affbox">Mervyn Singer</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>2</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139732525844768"><h3 class="no_margin">Jody Aberdein</h3><p><sup>1</sup>Senior House Officer, Department of Intensive Care Medicine, University College London Hospitals NHS Trust, Mortimer St, London, UK </p><div>Find articles by <a href="/pubmed/?term=Aberdein%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16356204">Jody Aberdein</a></div></div><div id="_co_idm139732524678928"><h3 class="no_margin">Mervyn Singer</h3><p><sup>2</sup>Professor, Dept of Intensive Care Medicine, University College London Hospitals NHS Trust, Mortimer St, London, UK </p><div>Find articles by <a href="/pubmed/?term=Singer%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16356204">Mervyn Singer</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139732519515664_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139732519515664_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139732519515664_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>Senior House Officer, Department of Intensive Care Medicine, University College London Hospitals NHS Trust, Mortimer St, London, UK </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>Professor, Dept of Intensive Care Medicine, University College London Hospitals NHS Trust, Mortimer St, London, UK </div><div><span class="fm-affl">Mervyn Singer, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@regnis.m" class="oemail">ku.ca.lcu@regnis.m</a></span>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139732519515664_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; BioMed Central Ltd 2005</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1550829/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><p id="__p1" class="p p-first-last">Traditional teaching suggests that corticosteroids should be avoided during acute infectious episodes for fear of compromising the immune response. However, the outcome benefit shown through steroid administration in early septic shock implies this paranoia may be misplaced. We therefore performed a systematic review of the literature to identify the current strength of evidence for the use of corticosteroids in specified infections, and to make appropriate graded recommendations.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Chronic Obstructive Pulmonary Disease, Bacterial Meningitis, Leprosy, Bronchiolitis, Tuberculous Meningitis</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Introduction</h2><p id="__p2" class="p p-first-last">Traditional teaching suggests that corticosteroids impair the ability of the body to fight infection and that this may prove catastrophic if an appropriate antibiotic is not chosen. In recent years, however, the early use of steroid therapy has become progressively established in a wide range of infective conditions [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255630">1</a>, <a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917001">2</a>], including septic shock, its most severe systemic manifestation. We thus decided to conduct a systematic review of the literature to identify the current strength of evidence for the use of corticosteroids in specified infections, and to make appropriate graded recommendations.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Methodology</h2><p id="__p3" class="p p-first">The Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effects (DARE) and the Cochrane Central Register of Controlled Trials (CENTRAL) (issue 1, 2005) were searched using medical subject headings (MeSH) for steroids, glucocorticoids, adrenal cortex hormones AND (virus diseases OR bacterial infections OR mycoses). In addition, phase 1 of the Cochrane highly sensitive strategy for randomised controlled trials [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255628">3</a>] AND a steroid search (Table <a href="/pmc/articles/PMC1550829/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1)</span></span><span>1</span></a>) AND search terms for specific clinical entities were utilised in both MEDLINE and EMBASE.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p4">Steroid search terms used in MEDLINE and EMBASE</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139732593019216" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">SEARCH: STEROI$</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">SEARCH: CORTICO$</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">SEARCH: GLUCOCORT$</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">SEARCH: CORTIS$</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">SEARCH: HYRDOCORTISONE</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">SEARCH: HYDROCORTISOL</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">SEARCH: PRED$</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">SEARCH: METHYLPRED$</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">SEARCH: METHYL ADJ PRED$</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">SEARCH: DEXAMET$</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">SEARCH: BECLOMET$</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">SEARCH: BUDESON$</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">SEARCH: TRIAMCIN$</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">SEARCH: FLUTIC$</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">SEARCH: 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14</td></tr></tbody></table></div><div id="largeobj_idm139732593019216" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1550829/table/Tab1/?report=objectonly">Open in a separate window</a></div></div><p id="__p5">Systematic reviews published since 1999 formed the mainstay of analysis. Trials published more recently, or not considered by the reviews, were also included. For infections with no prior review, original articles are summarised. The abstracts thus obtained were scanned for relevance, and the original papers retrieved. Specific clinical entities are reviewed in order of the strength of evidence, proceeding through meta-analyses of multiple well-controlled trials to single small studies and case reports.</p><p id="__p6" class="p p-last">Table <a href="/pmc/articles/PMC1550829/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table2</span></span><span>2</span></a> shows the systems used to grade the level of evidence and consequent level of recommendation for the use of corticosteroids for each specified infection.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p7">Grading system</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139732520471904" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><tbody><tr><td align="left" rowspan="1" colspan="1">Grading of recommendations</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">Supported by at least two level I investigations</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">B</td><td align="left" rowspan="1" colspan="1">Supported by one level I investigation</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">Supported by level II investigations only</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1">Supported by at least one level III investigation</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">E</td><td align="left" rowspan="1" colspan="1">Supported by level IV or V evidence</td></tr><tr><td align="left" rowspan="1" colspan="1">Grading of evidence</td><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">Evidence is based on randomised controlled trials (or meta-analysis of such trials) of adequate size to ensure a low risk of incorporating false-positive (alpha) or false-negative (beta) results</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">II</td><td align="left" rowspan="1" colspan="1">Evidence is based on randomised controlled trials that are too small to provide \'level I\' evidence. They may show either positive trends that are not statistically significant or no trends and are associated with a high risk of false-negative results</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">III</td><td align="left" rowspan="1" colspan="1">Evidence is based on non-randomised controlled or cohort studies, case series, case-control studies or cross-sectional studies</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">Evidence is based on non-randomised, historical controls and expert opinion</td></tr><tr><td rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">V</td><td align="left" rowspan="1" colspan="1">Evidence is based on case series, uncontrolled studies, and expert opinion</td></tr></tbody></table></div><div id="largeobj_idm139732520471904" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1550829/table/Tab2/?report=objectonly">Open in a separate window</a></div></div></div><div id="Sec3" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec3title">Conditions</h2><div id="Sec4" class="sec sec-first"><h3 id="Sec4title">Septic shock</h3><p id="__p8" class="p p-first">The use of steroids in septic shock has been the subject of controversy for five decades. The lack of benefit reported by two large multi-centre randomised trials [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917023">4</a>, <a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917012">5</a>] prompted two meta-analyses published in 1995 [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917006">6</a>, <a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917010">7</a>] to recommend that short courses of high dose steroids should no longer be used in patients with the sepsis syndrome. Subsequent studies in a sicker septic population, however, reported either survival benefit or reduction in catecholamine requirements with longer courses (&#x02265; 5 days) of lower stress doses of corticosteroids (200 to 300 mg hydrocortisone daily equivalent) [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255640">8</a>]. This strategic shift to an \'adrenal replacement\' dose (albeit the doses chosen will still generate supra-physiological levels) arose from the recognition that relative adrenal insufficiency was a common phenomenon in sepsis and a poor prognostic factor. A rebound increase in plasma cytokine levels at three days [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917025">9</a>] prompted the recommendation that the steroid dose should be tailed off rather than stopped abruptly.</p><p id="__p9">In view of the above, a recent Cochrane systematic review and accompanying publication re-examined the use of corticosteroids in septic shock [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255646">10</a>, <a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916988">11</a>]. Although there was no overall outcome benefit, subgroup analysis of trials using low dose steroids did show a significant reduction in 28 day mortality (relative risk (RR) 0.8 (confidence interval (CI) 0.67 to 0.95)), hospital mortality (RR 0.83 (CI 0.71 to 0.97)) and shock reversal at both 7 days (RR 1.6 (CI 1.01 to 2.01)) and 28 days (RR 1.21 (CI 1.04 to 1.52)).</p><p id="__p10" class="p">The largest study contributing to this subgroup analysis is worthy of individual consideration [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255647">8</a>]. Although contributing 27% weight to the review, this trial only demonstrated significant mortality reduction in a subgroup of patients showing a subnormal rise in plasma cortisol (&#x0003c;9 &#x003bc;g/l (248 nmol/l)) in response to stimulation by 250 &#x003bc;g tetracosactrin (synthetic adrenocorticotropic hormone (ACTH)). Some have since argued that all septic shock patients should receive corticosteroids regardless of tetracosactrin response on the grounds of lack of harm [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916982">12</a>], whereas others counsel caution in view of the risk of potential adverse events such as myopathy [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917017">13</a>]. A large multicentre European study (CORTICUS) is shortly to conclude and will hopefully provide more definitive data. Until then, we believe that steroids should be used only in tetracosactrin non-responders.</p><div id="Sec5" class="sec"><p></p><h4 id="Sec5title" class="inline">Recommendation 1 </h4><p id="__p11" class="p p-first">Low dose (200 to 300 mg) hydrocortisone equivalent/day for 7 days should be given to patients with a subnormal cortisol response (&#x0003c;9 &#x003bc;g/l (248 nmol/l)) following 250 &#x003bc;g tetracosactrin.</p><p id="__p12" class="p p-last">Grade of evidence I; grade of recommendation B.</p></div><div id="Sec6" class="sec"><p></p><h4 id="Sec6title" class="inline">Recommendation 2 </h4><p id="__p13" class="p p-first">Hydrocortisone can be started pending the laboratory results and discontinued if the rise in cortisol level following 250 &#x003bc;g tetracosactrin exceeds 9 &#x003bc;g/l.</p><p id="__p14" class="p p-last">Grade of evidence I; grade of recommendation B.</p></div><div id="Sec7" class="sec sec-last"><p></p><h4 id="Sec7title" class="inline">Recommendation 3 </h4><p id="__p15" class="p p-first">After the seven day course, the dose of corticosteroid should be tailed off over a further five to seven days.</p><p id="__p16" class="p p-last">Grade of evidence IV; grade of recommendation E.</p></div></div><div id="Sec8" class="sec"><h3 id="Sec8title">Acute bacterial meningitis</h3><p id="__p17" class="p p-first">A recent systematic review performed a per-protocol analysis of 1,853 (89%) of 2,064 enrolled patients, of all age groups, from 18 identified trials [<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255634">14</a>]. Corticosteroid therapy consisted of either dexamethasone (0.4 to 0.9 mg/kg), hydrocortisone, prednisolone, or a combination. The mortality rates with and without steroid therapy were 8.5% and 11.6%, respectively, providing a number needed to treat (NNT) of 33 to save one life. This increased to 280 in the subset of 742 children (steroid group mortality 6.2%, placebo 6.6%) but fell to 10 in adult patients (8% steroid, 17.8% placebo). The authors exercised caution over the adult data analysis due to methodological concerns over one major trial included.</p><p id="__p18">The causative organism appeared important in determining any outcome benefit from steroids. Significant benefit was found when treating <em>Streptococcus pneumoniae</em> and "species other than <em>Haemophilus influenzae</em>", though statistical significance was also not achieved with <em>Neisseria meningitides</em> infection.</p><p id="__p19">Hearing loss was significantly reduced (2.7% steroids, 7.7% control), providing a NNT of 20. The NNT was lowered to 15 in children (2.9% steroid, 9.8% control) where benefit was seen regardless of causative organism. Long-term neurological sequelae were reduced overall, but this did not achieve significance when age group or organism subset analyses were performed. A non-significant increase in gastrointestinal bleeding was noted, otherwise there were no associated adverse effects. A greater risk reduction occurred if steroid was given with or before the start of antibiotics. On the basis of this review, the authors recommend a regimen of dexamethasone 0.6 mg/kg daily for four days, started preferably before antibiotic therapy.</p><p id="__p20">A recently published study of 301 adult patients with bacterial meningitis adds further support to these findings [<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916997">15</a>]. Those randomised to receive dexamethasone showed an absolute reduction in death or disability from severe to moderate both overall (NNT 10) and in the <em>S. pneumoniae</em> subgroup (NNT 4). Statistical significance was not, however, achieved in reduction of neurological sequelae, including hearing loss. The authors recommend a dose of 10 mg dexamethasone qds for 48 hours, starting before antibiotic therapy [<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916995">16</a>], though reservations have been raised about this regimen for meningitis not caused by pneumococcus, and in the setting of sepsis [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917000">17</a>].</p><p id="__p21" class="p">The population setting may be of importance. A large randomised trial of paediatric meningitis in a developing country with late presentation of disease, high levels of resistance to available antimicrobials, and a higher prevalence of chronic disease and malnutrition demonstrated no effect either on survival or neurological sequelae [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917004">18</a>, <a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917021">19</a>].</p><div id="Sec9" class="sec sec-last"><p></p><h4 id="Sec9title" class="inline">Recommendation </h4><p id="__p22" class="p p-first">Dexamethasone 10 mg qds or equivalent should be given for 48 hours, preferably commencing prior to antibiotic therapy.</p><p id="__p23" class="p p-last">Grade of evidence I; grade of recommendation A.</p></div></div><div id="Sec10" class="sec"><h3 id="Sec10title"><em>Pneumocystis</em> pneumonia</h3><p id="__p24" class="p p-first">Patients with <em>Pneumocystis jiroveci</em> pneumonia may suffer deterioration in pulmonary function after initiation of antimicrobials. The efficacy of adjunctive corticosteroid therapy in avoiding this complication was investigated, leading to a consensus statement recommending its use in HIV positive adolescents or adults with moderate or severe disease [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917024">20</a>]. If the arterial partial pressure of oxygen (PaO<sub>2</sub>) is &#x0003c;9.3 kPa or the alveolar-arterial gradient &#x0003e;4.7 kPa, steroids should be started, preferably within 72 hours of admission.</p><p id="__p25">A randomised, non-blinded trial of prednisolone versus placebo in 251 HIV positive patients, mainly with confirmed <em>Pneumocystis</em> pneumonia, revealed a significant mortality reduction at 31 and 84 days [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917020">21</a>]. The likelihood of the combined endpoint of respiratory failure (defined as death, mechanical ventilation or a PaO<sub>2</sub>:FiO<sub>2</sub> ratio &#x0003c;10 kPa) was 2.3 times more common among eligible non-steroid treated patients. The NNT was 29 to gain benefit. Adverse effects included a significant increase in herpes reactivation, and possibly more oral thrush.</p><p id="__p26" class="p">Adjunctive steroid has previously been shown to prevent early deterioration of <em>Pneumocystis</em> pneumonia patients [<a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917027">22</a>, <a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916991">23</a>], though not to hasten recovery [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255651">24</a>]. Hence, steroids may not hasten recovery, but may avoid acute deterioration in a group of patients [<a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255632">25</a>].</p><div id="Sec11" class="sec sec-last"><p></p><h4 id="Sec11title" class="inline">Recommendation </h4><p id="__p27" class="p p-first">Prednisolone 40 mg twice daily for 5 days, then 40 mg daily for 5 days, then 20 mg daily for 10 days should be given to adult patients with PaO<sub>2</sub> &#x0003c;9.3 kPa or alveolar-arterial gradient &#x0003e;4.7 kPa.</p><p id="__p28" class="p p-last">Grade of evidence I; grade of recommendation A.</p></div></div><div id="Sec12" class="sec"><h3 id="Sec12title">Community acquired pneumonia</h3><p id="__p29" class="p p-first">In a small, recently published, multicentre trial, 46 patients with severe community-acquired pneumonia randomised to receive hydrocortisone (200 mg bolus followed by 10 mg/h infusion for 7 days) showed significant improvements in gas exchange, resolution of organ failure and reduction in hospital stay [<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917014">26</a>].</p><div id="Sec13" class="sec sec-last"><p></p><h4 id="Sec13title" class="inline">Recommendation </h4><p id="__p30" class="p p-first">Hydrocortisone (200 mg bolus followed by 10 mg/h infusion for 7 days) may be considered in severe community-acquired pneumonia.</p><p id="__p31" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec14" class="sec"><h3 id="Sec14title">SARS-related pneumonia</h3><p id="__p32" class="p p-first">Corticosteroid therapy (methylprednisolone or hydrocortisone) was routinely used during the outbreak of the coronavirus-associated severe acute respiratory syndrome (SARS) following early anecdotal reports of benefit. The rapid emergence of the syndrome prevented the establishment of randomised controlled trials. Two subsequent retrospective reviews [<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916987">27</a>, <a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916994">28</a>] from two different Hong Kong hospitals produced conficting results. One claimed greater benefit from initial therapy with pulse steroid methylprednisolone(&#x02265; 500 mg/day) in terms of supplemental oxygen requirements and better radiographic outcomes, though the need for intensive care unit admission, mechanical ventilation, and mortality rates were similar. The other study, however, reported that corticosteroid use was associated with a doubling in adverse outcomes (37.9% versus 16.7%) and a 20.7-fold increase in risk of either intensive care unit admission or mortality, independent of age and disease severity.</p><div id="Sec15" class="sec sec-last"><p></p><h4 id="Sec15title" class="inline">Recommendation </h4><p id="__p33" class="p p-first">Steroids cannot be recommended for treatment of SARS-related pneumonia.</p><p id="__p34" class="p p-last">Grade of evidence V; grade of recommendation E.</p></div></div><div id="Sec16" class="sec"><h3 id="Sec16title">Bronchiolitis and viral wheeze</h3><p id="__p35" class="p p-first">Viral bronchiolitis, usually due to respiratory syncytial virus, is a leading cause of respiratory failure in infants. A systematic review of randomised, controlled trials in mechanically ventilated infants totalling 140 patients found no significant decrease in the duration of ventilation or hospital admission with systemic dexamethasone [<a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917028">29</a>]. Other trials have shown benefit with steroids, with a reduction in hospital stay in non-ventilated infants [<a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255639">30</a>, <a href="#CR31" rid="CR31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916992">31</a>], and in the need for hospital admission for children presenting with bronchiolitis to the emergency room [<a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917013">32</a>].</p><p id="__p36">Cough and wheeze are common long-term sequelae of bronchiolitis. Nebulised budesonide given early did not significantly affect one-year outcome in 161 infants [<a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916989">33</a>]. No difference was also seen in time to discharge, re-admission rates, survival, or visits from a general practitioner, reflecting findings made by other groups [<a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917008">34</a>, <a href="#CR35" rid="CR35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916986">35</a>].</p><p id="__p37" class="p">The use of inhaled steroid for episodic viral wheeze of childhood did not reduce symptom severity, duration, or the need for hospital admission [<a href="#CR36" rid="CR36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255631">36</a>].</p><div id="Sec17" class="sec"><p></p><h4 id="Sec17title" class="inline">Recommendation 1 </h4><p id="__p38" class="p p-first">Steroids should not be used in children with bronchiolitis who are ventilated.</p><p id="__p39" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div><div id="Sec18" class="sec sec-last"><p></p><h4 id="Sec18title" class="inline">Recommendation 2 </h4><p id="__p40" class="p p-first">Steroids should be given to children with mild bronchiolitis or viral wheeze who present as outpatients. The best regimen is as yet undetermined.</p><p id="__p41" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec19" class="sec"><h3 id="Sec19title">Croup</h3><p id="__p42" class="p p-first">A Cochrane review of 24 studies involving 2,878 patients comparing any glucocorticoid to placebo demonstrated significant benefit from a single dose [<a href="#CR37" rid="CR37" class=" bibr popnode">37</a>]. Position on a validated croup scale was likely to be reduced, with a RR of re-admission to hospital of 0.5 (0.4 to 0.7; NNT 17), and a reduction in length of stay of 12 (5 to 19) hours. There was, however, no significant difference in the number of children requiring intubation.</p><div id="Sec20" class="sec sec-last"><p></p><h4 id="Sec20title" class="inline">Recommendation </h4><p id="__p43" class="p p-first">Steroids should be administered to children with croup. The optimal dose and route are yet to be defined.</p><p id="__p44" class="p p-last">Grade of evidence I; grade of recommendation A.</p></div></div><div id="Sec21" class="sec"><h3 id="Sec21title">Tuberculous meningitis</h3><p id="__p45" class="p p-first">Tuberculous meningitis carries a high mortality. Steroids have been used as adjunctive treatment since the 1950s yet, even so, mortality is still around 20% to 30%, with neurological sequelae common in survivors.</p><p id="__p46">A review of six studies totalling 595 patients with mild to severe disease showed a mortality reduction with steroids (RR 0.79 (CI 0.69 to 0.97), NNT 14) [<a href="#CR38" rid="CR38" class=" bibr popnode">38</a>]. Analysis by age suggested risk reduction only for those under 15 years old, although the total number of adults recruited was small. Mortality for mild disease was too rare to allow analysis. HIV status was not recorded in the trials analysed. There was considerable heterogeneity in the recording of adverse events and neurological sequelae. No study gave evidence of optimal treatment concealment. A funnel plot was suggestive of publication bias. Hence no firm recommendation could be given without further evidence.</p><p id="__p47" class="p">A recent trial involved 545 patients over age 14 from Vietnam with definite or probable tuberculous meningitis who were randomised to receive four weeks of tapering intravenous dexamethasone followed by four weeks of oral therapy, starting at 0.4 mg/kg for non-mild disease, and 0.3 mg/kg in mild cases [<a href="#CR39" rid="CR39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916985">39</a>, <a href="#CR40" rid="CR40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916998">40</a>]. At nine months the steroid group showed an absolute risk reduction in mortality of 9.2% over placebo (NNT 11). There was no significant reduction for death and severe disability combined, perhaps because of the study power, or the way in which disability was measured. HIV infection was associated with higher mortality, but no effect of steroid was seen in this subgroup. Adverse events were lower in the steroid group, particularly those that led to a change in anti-tuberculous therapy, such as drug-induced hepatitis. As a change in therapy was associated with death, this is a possible mechanism for the mortality reduction effect of steroids.</p><div id="Sec22" class="sec sec-last"><p></p><h4 id="Sec22title" class="inline">Recommendation </h4><p id="__p48" class="p p-first">Dexamethasone tapering over four weeks, from 0.4 mg/kg or 0.3 mg/kg depending upon severity, should be administered for tuberculous meningitis.</p><p id="__p49" class="p p-last">Grade of evidence I; grade of recommendation A.</p></div></div><div id="Sec23" class="sec"><h3 id="Sec23title">Tuberculous pericarditis</h3><p id="__p50" class="p p-first">A review of four trials involving 469 patients showed a trend to reduced mortality and persistence of disease [<a href="#CR41" rid="CR41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255637">41</a>]. Statistical significance for a reduced mortality was only reached for those with tuberculous effusion (RR 0.48 (CI 0.29 to 0.8)), but this significance was lost on intention-to-treat analysis. Subgroup analysis of HIV positive individuals did not show significant results.</p><p id="__p51" class="p">A recent randomised trial of 383 South African patients stratified patients by disease type, namely constrictive, effusive with drainage, or effusive with conservative management [<a href="#CR42" rid="CR42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255635">42</a>]. The effect of prednisolone on mortality, functional status and need for repeat pericardiocentesis was studied. The prednisolone group showed a trend towards improved overall survival, but it did significantly decrease the composite endpoint of death and adverse outcome (NNT 5), mainly as it reduced the need for pericardectomy and its associated mortality. Upon correction for age and gender, deaths from tuberculous pericarditis were significantly reduced. There was no significant effect on functional status at 10 years.</p><div id="Sec24" class="sec sec-last"><p></p><h4 id="Sec24title" class="inline">Recommendation </h4><p id="__p52" class="p p-first">Prednisolone tapering from 60 mg daily (adult dose) over 11 weeks should be given in tuberculous pericarditis.</p><p id="__p53" class="p p-last">Grade of evidence I; grade of recommendation A.</p></div></div><div id="Sec25" class="sec"><h3 id="Sec25title">Tuberculous pleurisy</h3><p id="__p54" class="p p-first">Three small trials investigating the use of steroids in tuberculous pleurisy were analysed in a systematic review [<a href="#CR43" rid="CR43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255643">43</a>]. These were not scaled to measure mortality, thus steroids were not recommended on this basis. Significance was not reached for reduction of symptomatology in the acute phase, or reduced pleural sequelae.</p><p id="__p55" class="p">A more recent trial of 197 HIV positive patients with pleural tuberculosis showed no significant reduction in mortality, a non-significant increase in recurrence, and a higher rate of Kaposi sarcoma in the steroid-treated group [<a href="#CR44" rid="CR44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917022">44</a>]. Hence there can as yet be no recommendation for the use of steroids in this group, and the evidence is still lacking for non-HIV infected individuals.</p><div id="Sec26" class="sec"><p></p><h4 id="Sec26title" class="inline">Recommendation 1 </h4><p id="__p56" class="p p-first">Steroids should not be given for tuberculous pleurisy in HIV positive patients.</p><p id="__p57" class="p p-last">Grade of evidence I; grade of recommendation B.</p></div><div id="Sec27" class="sec sec-last"><p></p><h4 id="Sec27title" class="inline">Recommendation 2 </h4><p id="__p58" class="p p-first">Steroids cannot yet be recommended for tuberculous pleurisy in non-HIV positive patients.</p><p id="__p59" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec28" class="sec"><h3 id="Sec28title">Pulmonary tuberculosis</h3><p id="__p60" class="p p-first">Various clinical and other indices were improved by the use of steroids in pulmonary tuberculosis according to a review of 11 studies [<a href="#CR45" rid="CR45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255644">45</a>]. Significant improvement was seen in time to defervescence, weight gain, hospital stay and inflammatory markers. X-ray appearances, both for infiltration and cavitation, were faster to resolve. Sputum smear or culture positivity was not altered. The heterogeneity of these studies did not enable the reviewers to perform overall statistical analysis. It should be borne in mind, however, that most of these studies predate 1970 and were conducted before the advent of rifampicin. The results should thus be treated cautiously.</p><p id="__p61">Systemic steroid therapy has also been suggested to improve bronchoscopic and radiographic resolution of tuberculous bronchial obstruction in children in randomised studies of 117 and 29 patients [<a href="#CR46" rid="CR46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255652">46</a>, <a href="#CR47" rid="CR47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916996">47</a>].</p><p id="__p62" class="p">A recent study in HIV-associated tuberculosis [<a href="#CR48" rid="CR48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916993">48</a>], however, suggested that the benefits of prednisolone therapy on immune activation and CD4(+) T cell counts did not outweigh the risks of adverse events (a transient increase in HIV RNA levels, worsening of underlying hypertension, fluid retention and hyperglycemia).</p><div id="Sec29" class="sec sec-last"><p></p><h4 id="Sec29title" class="inline">Recommendation </h4><p id="__p63" class="p p-first">Steroids may be considered for patients with pulmonary tuberculosis, particularly those with extensive disease, but not in HIV-positive patients.</p><p id="__p64" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec30" class="sec"><h3 id="Sec30title">Chronic obstructive pulmonary disease</h3><p id="__p65" class="p p-first">Ten randomized controlled trials, totalling 951 patients, of different regimens of systemic steroids for exacerbations of chronic obstructive pulmonary diseases were recently analysed [<a href="#CR49" rid="CR49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255626">49</a>]. The primary endpoint was treatment failure defined as the need for extra or repeated treatment of the exacerbation, or mortality. Steroids reduced this risk (odds ratio 0.48 (CI 0.34 to 0.68), NNT 9) but no difference was seen in mortality. There was improvement in breathlessness, and in measures such as forced expiratory volume in 1 second (FEV<sub>1</sub>) and arterial blood gas tests. Hospital stay was not reduced, possibly due to heterogeneity of discharge policy and co-morbidity. Adverse events were more likely with the number needed to harm being 6 overall, and 13 for hyperglycaemia. A further review confirmed a reduction in treatment failure and also a reduced length of hospital stay [<a href="#CR50" rid="CR50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917016">50</a>]. This review suggested that two weeks of steroid therapy was as effective as eight, with less associated infection risk. Long-term inhaled steroids also reduced the risk of acute exacerbation in a subgroup of patients with FEV<sub>1</sub>&#x0003c;2L (RR 0.75 (CI 0.71 to 0.8)) [<a href="#CR51" rid="CR51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255633">51</a>].</p><div id="Sec31" class="sec sec-last"><p></p><h4 id="Sec31title" class="inline">Recommendation </h4><p id="__p66" class="p p-first">Short course oral steroid should be given for exacerbations of chronic obstructive pulmonary disease. This may be in the form of 30 mg prednisolone daily for 14 days.</p><p id="__p67" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec32" class="sec"><h3 id="Sec32title">Cystic fibrosis</h3><p id="__p68" class="p p-first">A review of 10 trials of inhaled steroids in cystic fibrosis did not find any difference in lung function testing, or the number of days treatment with antibiotics [<a href="#CR52" rid="CR52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255636">52</a>].</p><div id="Sec33" class="sec sec-last"><p></p><h4 id="Sec33title" class="inline">Recommendation </h4><p id="__p69" class="p p-first">Inhaled steroids should not be administered routinely in cystic fibrosis patients.</p><p id="__p70" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec34" class="sec"><h3 id="Sec34title">Chronic hepatitis B</h3><p id="__p71" class="p p-first">A systematic review found 13 adequate trials of steroid therapy prior to interferon-&#x003b1; involving 790 patients [<a href="#CR53" rid="CR53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255629">53</a>]. Pre-treatment with four to six weeks of steroids showed improved clearance of markers of infection such as hepatitis e antigen and hepatitis B DNA. There was, however, no difference in mortality, hepatitis B surface antigen, hepatitis B e antibody, liver histology, or quality of life. Adverse events were equally distributed. The authors concluded that recommendation would require an improvement in clinical outcome that was not seen.</p><div id="Sec35" class="sec sec-last"><p></p><h4 id="Sec35title" class="inline">Recommendation </h4><p id="__p72" class="p p-first">Steroids should not be used for pre-treatment of chronic hepatitis B.</p><p id="__p73" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec36" class="sec"><h3 id="Sec36title">Chronic hepatitis C</h3><p id="__p74" class="p p-first">A review found eight randomised trials that examined corticosteroids in chronic hepatitis C [<a href="#CR54" rid="CR54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255642">54</a>]. Protocols and patient groups showed significant heterogeneity, with use of steroid alone or in combination with interferon, and comparison against placebo or interferon. There was no effect on all-cause or liver-related mortality, virological response, biochemistry, or liver biopsy findings. One trial reported a significant reduction in side-effects of interferon with concurrent steroid use.</p><div id="Sec37" class="sec sec-last"><p></p><h4 id="Sec37title" class="inline">Recommendation </h4><p id="__p75" class="p p-first">Steroids should not be used for treatment of chronic hepatitis C.</p><p id="__p76" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec38" class="sec"><h3 id="Sec38title">Acute viral hepatitis</h3><p id="__p77" class="p p-first">A trial involving 300 patients with acute viral hepatitis studied methylprednisolone tapering from 48 mg daily over 12 weeks [<a href="#CR55" rid="CR55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917009">55</a>]. There was no benefit with steroids. Indeed, there was a non-significant trend towards increased mortality. Hospital stay, time to symptom resolution, and most biochemical markers were unaffected.</p><div id="Sec39" class="sec sec-last"><p></p><h4 id="Sec39title" class="inline">Recommendation </h4><p id="__p78" class="p p-first">Steroids should not be used for treatment of acute viral hepatitis.</p><p id="__p79" class="p p-last">Grade of evidence II; grade of recommendation B.</p></div></div><div id="Sec40" class="sec"><h3 id="Sec40title">Idiopathic facial nerve (Bell\'s) palsy</h3><p id="__p80" class="p p-first">A review considered 4 trials, with 179 patients [<a href="#CR56" rid="CR56" class=" bibr popnode">56</a>]. There was no improvement in recovery of motor function, or presence of synkinesis or autonomic dysfunction. This result is at odds with previously published analyses, which have recommended steroids. The authors note that prior analyses include a study with a loss to follow up of 29%, and that significance is lost with the exclusion of this trial.</p><div id="Sec41" class="sec sec-last"><p></p><h4 id="Sec41title" class="inline">Recommendation </h4><p id="__p81" class="p p-first">Steroids should not be used to treat Bell\'s palsy.</p><p id="__p82" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec42" class="sec"><h3 id="Sec42title">Malaria</h3><p id="__p83" class="p p-first">Adjunctive steroid has been used to improve mortality and neurological sequelae, both of which are common.</p><p id="__p84">A review found two adequate trials with a total of 143 patients [<a href="#CR57" rid="CR57" class=" bibr popnode">57</a>]. Mortality did not improve with dexamethasone. Trials so far have been too small, however, to exclude an effect. One study suggested that steroid use increases the time to recovery from coma and, therefore, may be detrimental [<a href="#CR58" rid="CR58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917003">58</a>]. Hence there can be no recommendation thus far.</p><p id="__p85" class="p">A small trial of steroid in treating nephrotic syndrome as a result of plasmodium malaria found there to be no reduction of proteinuria [<a href="#CR59" rid="CR59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255638">59</a>].</p><div id="Sec43" class="sec"><p></p><h4 id="Sec43title" class="inline">Recommendation 1 </h4><p id="__p86" class="p p-first">Steroids should not be used to treat cerebral malaria.</p><p id="__p87" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div><div id="Sec44" class="sec sec-last"><p></p><h4 id="Sec44title" class="inline">Recommendation 2 </h4><p id="__p88" class="p p-first">Steroids should not be used to treat nephrotic syndrome secondary to malaria.</p><p id="__p89" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec45" class="sec"><h3 id="Sec45title">Typhoid</h3><p id="__p90" class="p p-first">A case control study of 374 blood culture confirmed severe typhoid cases in Papua New Guinea found that 400 mg hydrocortisone 6 hourly for 12 doses did not improve mortality [<a href="#CR60" rid="CR60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255641">60</a>]. This finding is in contrast to earlier randomised studies [<a href="#CR61" rid="CR61" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255627">61</a>].</p><p id="__p91">A trial of 38 patients in Jakarta examining dexamethasone 3 mg/kg followed by 1 mg/kg for a further 8 doses gave a case fatality of 2/20 for steroid treatment versus 10/18 for placebo (NNT of 3) [<a href="#CR62" rid="CR62" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917011">62</a>]. The investigators later published a case control series of 41 patients with similar mortality reduction. A partially blinded trial of steroids as adjunct to surgery in typhoid perforation gave a similar mortality reduction, again with trial numbers being small [<a href="#CR63" rid="CR63" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255648">63</a>].</p><p id="__p92" class="p">Given the dramatic reduction in mortality, steroids have been recommended in higher dose for severe typhoid, particularly with shock, delirium, or coma, after the exclusion of other bacterial meningitis (but see above).</p><div id="Sec46" class="sec sec-last"><p></p><h4 id="Sec46title" class="inline">Recommendation </h4><p id="__p93" class="p p-first">Steroids should be used in severe typhoid.</p><p id="__p94" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec47" class="sec"><h3 id="Sec47title">Septic arthritis</h3><p id="__p95" class="p p-first">The effect of adjuvant dexamethasone compared to antibiotics alone was studied in one randomized controlled trial [<a href="#CR64" rid="CR64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916984">64</a>]. Children aged between 3 months and 13 years with a diagnosis of septic arthritis were given either placebo or 0.2 mg/kg dexamethasone for four days from diagnosis.</p><p id="__p96" class="p">The steroid group had significantly less joint dysfunction at the time of finishing treatment (2/50 versus 16/50; NNT 4), at 6 months (1/50 versus 19/50; NNT 3) and 12 months follow up (1/50 versus 13/50; NNT 5). Details were not given of adverse events related to steroid use. Residual dysfunction seemed more likely with <em>Staphylococcus aureus</em> infection, but trial numbers precluded subgroup analysis.</p><div id="Sec48" class="sec sec-last"><p></p><h4 id="Sec48title" class="inline">Recommendation </h4><p id="__p97" class="p p-first">Dexamethasone 0.2 mg/kg for 4 days should be given for haematogenous septic arthritis.</p><p id="__p98" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec49" class="sec"><h3 id="Sec49title">Dengue shock syndrome</h3><p id="__p99" class="p p-first">In the absence of a specific antiviral agent, high doses of glucocorticoid and fluid rehydration have been used to treat Dengue shock syndrome. Steroid use has been supported by an early study of 98 patients. [<a href="#CR65" rid="CR65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255653">65</a>]. This finding has not been confirmed with more recent trials, there being no case fatality difference amongst the 97 and 63 children randomised in each study [<a href="#CR66" rid="CR66" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917019">66</a>, <a href="#CR67" rid="CR67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916999">67</a>]. One caveat is that the observed mortality rate was lower than expected, thus under-powering the trials, and leaving the possibility of a steroid effect. Steroids cannot yet be recommended on this basis for Dengue shock syndrome.</p><div id="Sec50" class="sec sec-last"><p></p><h4 id="Sec50title" class="inline">Recommendation </h4><p id="__p100" class="p p-first">Steroids should not be used for Dengue shock syndrome.</p><p id="__p101" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec51" class="sec"><h3 id="Sec51title">Infectious mononucleosis</h3><p id="__p102" class="p p-first">One recent trial of single dose dexamethasone 0.3 mg/kg administered to adolescents with suspected Epstein-Barr virus (EBV) pharyngitis gave improved pain score on visual analogue scale at 12 hours but not thereafter [<a href="#CR68" rid="CR68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255650">68</a>]. An earlier trial combining acyclovir with prednisolone had no effect on either the duration of clinical symptoms or the development of EBV-specific cellular immunity [<a href="#CR69" rid="CR69" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917018">69</a>]. A further non-randomized study of 22 patients with impending airway obstruction demonstrated more rapid clinical improvement with steroid, although none of the control group actually developed airway obstruction [<a href="#CR70" rid="CR70" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917002">70</a>].</p><div id="Sec52" class="sec sec-last"><p></p><h4 id="Sec52title" class="inline">Recommendation </h4><p id="__p103" class="p p-first">Steroids may be of benefit in infectious mononucleosis if there is respiratory compromise or severe pharyngeal oedema.</p><p id="__p104" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec53" class="sec"><h3 id="Sec53title">Bordatella pertussis</h3><p id="__p105" class="p p-first">A review found only one randomized trial of steroid use in whooping cough in infants, with only seven trial participants, leading to a non-significant effect on cough reduction or duration of hospital stay [<a href="#CR71" rid="CR71" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255649">71</a>].</p><div id="Sec54" class="sec sec-last"><p></p><h4 id="Sec54title" class="inline">Recommendation </h4><p id="__p106" class="p p-first">Steroids should not be administered for whooping cough in infants.</p><p id="__p107" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec55" class="sec"><h3 id="Sec55title">Leprosy</h3><p id="__p108" class="p p-first">Steroids are recommended by the WHO for new nerve damage in leprosy [<a href="#CR72" rid="CR72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845255645">72</a>]. This recommendation is, however, based on expert opinion and a recent review highlighted a lack of controlled trials [<a href="#CR73" rid="CR73" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916990">73</a>]. Case series have demonstrated improved nerve function in up to 88% of ambulatory patients after 40 mg prednisolone daily for 12 to 20 weeks. A recent trial of prophylactic 20 mg prednisolone daily to prevent reversal reaction after treatment resulted in a significant reduction in nerve damage at 4 months, but no statistically significant change at 12 months (albeit a 23% relative decrease) [<a href="#CR74" rid="CR74" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917007">74</a>]. A trial of higher dose prednisolone, tapering from 40 mg daily over 16 weeks, for established impaired nerve function did not show any greater likelihood of improvement compared with placebo among the 95 people enrolled [<a href="#CR75" rid="CR75" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917026">75</a>].</p><div id="Sec56" class="sec"><p></p><h4 id="Sec56title" class="inline">Recommendation 1 </h4><p id="__p109" class="p p-first">Prednisolone 40 mg daily for 12 to 20 weeks should be used to treat reversal reaction causing new nerve function impairment in leprosy.</p><p id="__p110" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div><div id="Sec57" class="sec"><p></p><h4 id="Sec57title" class="inline">Recommendation 2 </h4><p id="__p111" class="p p-first">Steroids should not be used as prophylaxis for leprosy reversal reaction.</p><p id="__p112" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div><div id="Sec58" class="sec sec-last"><p></p><h4 id="Sec58title" class="inline">Recommendation 3 </h4><p id="__p113" class="p p-first">Steroids should not be used to treat established impaired nerve function in leprosy.</p><p id="__p114" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec59" class="sec"><h3 id="Sec59title">Onchocerciasis</h3><p id="__p115" class="p p-first">Onchocerca volvulus microfilariae are usually treated with ivermectin. When diethlycarbamazine is used there is a significantly increased chance of reaction to the lysed microfilariae. This Mazzotti reaction comprises itching, rash, fever, tachycardia and hypotension, and is sometimes fatal. A small trial of 40 patients demonstrated that the cardiovascular, but not cutaneous, aspects of this reaction could be alleviated by the use of three days of prednisolone 20 mg three times daily [<a href="#CR76" rid="CR76" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917005">76</a>, <a href="#CR77" rid="CR77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844917015">77</a>].</p><div id="Sec60" class="sec sec-last"><p></p><h4 id="Sec60title" class="inline">Recommendation </h4><p id="__p116" class="p p-first">Prednisolone 60 mg daily for 3 days should be used in treating the Mazzotti reaction.</p><p id="__p117" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div><div id="Sec61" class="sec sec-last"><h3 id="Sec61title">Cysticercosis</h3><p id="__p118" class="p p-first">In patients with solitary granuloma stage neurocysticercosis, a small trial of 108 patients has suggested that 1 mg/kg prednisolone for 10 days after the new onset of seizures, as well as anti-epileptic medicine, may result in a higher chance of lesion resolution, and a higher chance of remaining seizure free [<a href="#CR78" rid="CR78" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844916983">78</a>].</p><div id="Sec62" class="sec sec-last"><p></p><h4 id="Sec62title" class="inline">Recommendation </h4><p id="__p119" class="p p-first">Prednisolone 1 mg/kg for 10 days should be used to treat solitary granuloma stage neurocysticercosis.</p><p id="__p120" class="p p-last">Grade of evidence II; grade of recommendation C.</p></div></div></div><div id="Sec63" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec63title">Conclusion</h2><p id="__p121" class="p p-first-last">We present a synthesis of the diverse evidence related to steroid use in infections. A more detailed consideration of the applicability of steroids can be found in some condition-specific reviews, many of which are cited above. The conditions we have covered range widely in severity, duration, site, and type of causative organism. Furthermore, the dosing and duration of steroid therapy varies enormously between conditions and, as clearly illustrated by steroid use in sepsis, benefit or harm may accrue depending on the regimen used. In many of the conditions listed, only limited data are available. There is an obvious need to have more adequately powered trials to provide definitive evidence of benefit or harm, and a better understanding of how steroids modulate disease processes.</p></div><div id="idm139732594727344" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139732594727344title">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>CI</td><td>confidence interval</td></tr><tr><td>EBV</td><td>Epstein-Barr virus</td></tr><tr><td>FEV<sub>1</sub></td><td>forced expiratory volume in 1 second</td></tr><tr><td>NNT</td><td>number needed to treat</td></tr><tr><td>PaO<sub>2</sub></td><td>arterial partial pressure of oxygen</td></tr><tr><td>RR</td><td>relative risk</td></tr><tr><td>SARS</td><td>severe acute respiratory syndrome.</td></tr></tbody></table></div></div></div><div id="idm139732521708128" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139732521708128title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139732521708000"><p id="__p129" class="p p-first"><strong>Competing interests</strong></p><p id="__p130" class="p p-last">The author(s) declare that they have no competing interests.</p></p></div></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Thompson J. Role of glucocorticosteroids in the treatment of infectious diseases. <span><span class="ref-journal">Eur J Clin Microbiol Infect Dis. </span>1993;<span class="ref-vol">12</span>(Suppl 1):68\xe2\x80\x9372. doi: 10.1007/BF02389882.</span> [<a href="/pubmed/8477768" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2FBF02389882" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Clin+Microbiol+Infect+Dis&amp;title=Role+of+glucocorticosteroids+in+the+treatment+of+infectious+diseases&amp;author=J+Thompson&amp;volume=12&amp;issue=Suppl+1&amp;publication_year=1993&amp;pages=68-72&amp;doi=10.1007/BF02389882&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">McGowan JE, Chesney PJ, Crossley KB, LaForce FM. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. <span><span class="ref-journal">J Infect Dis. </span>1992;<span class="ref-vol">165</span>:1\xe2\x80\x9313. doi: 10.1093/infdis/165.1.1.</span> [<a href="/pubmed/1727879" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Finfdis%2F165.1.1" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Guidelines+for+the+use+of+systemic+glucocorticosteroids+in+the+management+of+selected+infections&amp;author=JE+McGowan&amp;author=PJ+Chesney&amp;author=KB+Crossley&amp;author=FM+LaForce&amp;volume=165&amp;publication_year=1992&amp;pages=1-13&amp;pmid=1727879&amp;doi=10.1093/infdis/165.1.1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Roberson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. <span><span class="ref-journal">Intl J Epidemiol. </span>2002;<span class="ref-vol">31</span>:150\xe2\x80\x93155. doi: 10.1093/ije/31.1.150.</span> [<a href="/pubmed/11914311" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fije%2F31.1.150" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Intl+J+Epidemiol&amp;title=Development+of+a+highly+sensitive+search+strategy+for+the+retrieval+of+reports+of+controlled+trials+using+PubMed&amp;author=KA+Roberson&amp;author=K+Dickersin&amp;volume=31&amp;publication_year=2002&amp;pages=150-155&amp;doi=10.1093/ije/31.1.150&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Bone RG, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. <span><span class="ref-journal">N Engl J Med. </span>1987;<span class="ref-vol">317</span>:653\xe2\x80\x93658. doi: 10.1056/NEJM198709103171101.</span> [<a href="/pubmed/3306374" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJM198709103171101" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+controlled+clinical+trial+of+high-dose+methylprednisolone+in+the+treatment+of+severe+sepsis+and+septic+shock&amp;author=RG+Bone&amp;author=CJ+Fisher&amp;author=TP+Clemmer&amp;author=GJ+Slotman&amp;author=CA+Metz&amp;volume=317&amp;publication_year=1987&amp;pages=653-658&amp;pmid=3306374&amp;doi=10.1056/NEJM198709103171101&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">The Veterans Administration Systemic Sepsis Cooperative Study Group  Effect of high-dose glucocorticosteroid therapy on mortality in patients with clinical signs of systemic sepsis. <span><span class="ref-journal">N Engl J Med. </span>1987;<span class="ref-vol">317</span>:659\xe2\x80\x93665. doi: 10.1056/NEJM198709103171102.</span> [<a href="/pubmed/2888017" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJM198709103171102" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Effect+of+high-dose+glucocorticosteroid+therapy+on+mortality+in+patients+with+clinical+signs+of+systemic+sepsis&amp;volume=317&amp;publication_year=1987&amp;pages=659-665&amp;pmid=2888017&amp;doi=10.1056/NEJM198709103171102&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Lefering R, Neugebauer E. Steroid controversy in sepsis and septic shock: a meta-analysis. <span><span class="ref-journal">Crit Care Med. </span>1995;<span class="ref-vol">23</span>:1294\xe2\x80\x931303. doi: 10.1097/00003246-199507000-00021.</span> [<a href="/pubmed/7600840" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F00003246-199507000-00021" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care+Med&amp;title=Steroid+controversy+in+sepsis+and+septic+shock:+a+meta-analysis&amp;author=R+Lefering&amp;author=E+Neugebauer&amp;volume=23&amp;publication_year=1995&amp;pages=1294-1303&amp;pmid=7600840&amp;doi=10.1097/00003246-199507000-00021&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Cronin L, Cook DJ, Carlet J, et al.  Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. <span><span class="ref-journal">Crit Care Med. </span>1995;<span class="ref-vol">23</span>:1430\xe2\x80\x931439. doi: 10.1097/00003246-199508000-00019.</span> [<a href="/pubmed/7634816" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F00003246-199508000-00019" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care+Med&amp;title=Corticosteroid+treatment+for+sepsis:+A+critical+appraisal+and+meta-analysis+of+the+literature&amp;author=L+Cronin&amp;author=DJ+Cook&amp;author=J+Carlet&amp;volume=23&amp;publication_year=1995&amp;pages=1430-1439&amp;pmid=7634816&amp;doi=10.1097/00003246-199508000-00019&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. <span><span class="ref-journal">J Am Med Assoc. </span>2002;<span class="ref-vol">288</span>:862\xe2\x80\x93871. doi: 10.1001/jama.288.7.862.</span> [<a href="/pubmed/12186604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1001%2Fjama.288.7.862" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Med+Assoc&amp;title=Effect+of+treatment+with+low+doses+of+hydrocortisone+and+fludrocortisone+on+mortality+in+patients+with+septic+shock&amp;author=D+Annane&amp;author=V+Sebille&amp;author=C+Charpentier&amp;author=PE+Bollaert&amp;author=B+Francois&amp;volume=288&amp;publication_year=2002&amp;pages=862-871&amp;doi=10.1001/jama.288.7.862&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2003;<span class="ref-vol">167</span>:512\xe2\x80\x93520. doi: 10.1164/rccm.200205-446OC.</span> [<a href="/pubmed/12426230" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200205-446OC" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Immunologic+and+hemodynamic+effects+of+&quot;low-dose&quot;+hydrocortisone+in+septic+shock:+a+double-blind,+randomized,+placebo-controlled,+crossover+study&amp;author=D+Keh&amp;author=T+Boehnke&amp;author=S+Weber-Cartens&amp;author=C+Schulz&amp;author=O+Ahlers&amp;volume=167&amp;publication_year=2003&amp;pages=512-520&amp;pmid=12426230&amp;doi=10.1164/rccm.200205-446OC&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y.  <span class="ref-journal">Corticosteroids for treating severe sepsis and septic shock.</span> 2004.  [<a href="/pubmed/14973984" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Corticosteroids+for+treating+severe+sepsis+and+septic+shock&amp;author=D+Annane&amp;author=E+Bellissant&amp;author=PE+Bollaert&amp;author=J+Briegel&amp;author=D+Keh&amp;publication_year=2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. <span><span class="ref-journal">Br Med J. </span>2004;<span class="ref-vol">329</span>:480\xe2\x80\x93488. doi: 10.1136/bmj.38181.482222.55.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC515196/">PMC free article</a>]</span> [<a href="/pubmed/15289273" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fbmj.38181.482222.55" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+Med+J&amp;title=Corticosteroids+for+severe+sepsis+and+septic+shock:+a+systematic+review+and+meta-analysis&amp;author=D+Annane&amp;author=E+Bellissant&amp;author=PE+Bollaert&amp;author=J+Briegel&amp;author=D+Keh&amp;volume=329&amp;publication_year=2004&amp;pages=480-488&amp;pmid=15289273&amp;doi=10.1136/bmj.38181.482222.55&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. Corticosteroids for septic shock. <span><span class="ref-journal">Ann Intern Med. </span>2004;<span class="ref-vol">141</span>:742\xe2\x80\x93743. doi: 10.7326/0003-4819-141-9-200411020-00032.</span> [<a href="/pubmed/15520444" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.7326%2F0003-4819-141-9-200411020-00032" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Corticosteroids+for+septic+shock&amp;author=PC+Minneci&amp;author=KJ+Deans&amp;author=SM+Banks&amp;author=PQ+Eichacker&amp;author=C+Natanson&amp;volume=141&amp;publication_year=2004&amp;pages=742-743&amp;pmid=15520444&amp;doi=10.7326/0003-4819-141-9-200411020-00032&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Luce JM. Physicians should administer low-dose corticosteroids selectively to septic patients until an ongoing trial is completed. <span><span class="ref-journal">Ann Intern Med. </span>2004;<span class="ref-vol">141</span>:70\xe2\x80\x9372. doi: 10.7326/0003-4819-141-1-200407060-00019.</span> [<a href="/pubmed/15238374" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.7326%2F0003-4819-141-1-200407060-00019" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Physicians+should+administer+low-dose+corticosteroids+selectively+to+septic+patients+until+an+ongoing+trial+is+completed&amp;author=JM+Luce&amp;volume=141&amp;publication_year=2004&amp;pages=70-72&amp;pmid=15238374&amp;doi=10.7326/0003-4819-141-1-200407060-00019&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">van de Beek D, de Gans J, McIntyre P, Prasad K.  <span class="ref-journal">Corticosteroids in acute bacterial meningitis.</span> 2003.  [<a href="/pubmed/12918010" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Corticosteroids+in+acute+bacterial+meningitis&amp;author=D+van+de+Beek&amp;author=J+de+Gans&amp;author=P+McIntyre&amp;author=K+Prasad&amp;publication_year=2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. <span><span class="ref-journal">N Engl J Med. </span>2002;<span class="ref-vol">347</span>:1549\xe2\x80\x931556. doi: 10.1056/NEJMoa021334.</span> [<a href="/pubmed/12432041" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa021334" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Dexamethasone+in+adults+with+bacterial+meningitis&amp;author=J+de+Gans&amp;author=D+van+de+Beek&amp;volume=347&amp;publication_year=2002&amp;pages=1549-1556&amp;pmid=12432041&amp;doi=10.1056/NEJMoa021334&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">van de Beek D, de Gans J, McIntyre P, Prasad K. Steroids in adults with acute bacterial meningitis: a systematic review. <span><span class="ref-journal">Lancet Infect Dis. </span>2004;<span class="ref-vol">4</span>:139\xe2\x80\x93143. doi: 10.1016/S1473-3099(04)00937-5.</span> [<a href="/pubmed/14998499" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS1473-3099(04)00937-5" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Infect+Dis&amp;title=Steroids+in+adults+with+acute+bacterial+meningitis:+a+systematic+review&amp;author=D+van+de+Beek&amp;author=J+de+Gans&amp;author=P+McIntyre&amp;author=K+Prasad&amp;volume=4&amp;publication_year=2004&amp;pages=139-143&amp;pmid=14998499&amp;doi=10.1016/S1473-3099(04)00937-5&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Suh KN. Dexamethasone in adults with bacterial meningitis. <span><span class="ref-journal">Can Med Assoc J. </span>2003;<span class="ref-vol">168</span>:740\xe2\x80\x93744.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC154925/">PMC free article</a>]</span> [<a href="/pubmed/12642433" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Can+Med+Assoc+J&amp;title=Dexamethasone+in+adults+with+bacterial+meningitis&amp;author=KN+Suh&amp;volume=168&amp;publication_year=2003&amp;pages=740-744&amp;pmid=12642433&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, Kayira K, Bwanaisa L, Njobvu A, Rogerson S, Malenga G. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. <span><span class="ref-journal">Lancet. </span>2002;<span class="ref-vol">360</span>:211\xe2\x80\x93218. doi: 10.1016/S0140-6736(02)09458-8.</span> [<a href="/pubmed/12133656" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(02)09458-8" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Dexamethasone+treatment+in+childhood+bacterial+meningitis+in+Malawi:+a+randomised+controlled+trial&amp;author=EM+Molyneux&amp;author=AL+Walsh&amp;author=H+Forsyth&amp;author=M+Tembo&amp;author=J+Mwenechanya&amp;volume=360&amp;publication_year=2002&amp;pages=211-218&amp;pmid=12133656&amp;doi=10.1016/S0140-6736(02)09458-8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Molyneux EM, Tembo M, Kayira K, Bwanaisa L, Mweneychanya J, Njobvu A, Forsyth H, Rogerson S, Walsh AL, Molyneux ME. The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi. <span><span class="ref-journal">Arch Dis Child. </span>2003;<span class="ref-vol">88</span>:1112\xe2\x80\x931118. doi: 10.1136/adc.88.12.1112.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1719398/">PMC free article</a>]</span> [<a href="/pubmed/14670782" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fadc.88.12.1112" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Dis+Child&amp;title=The+effect+of+HIV+infection+on+paediatric+bacterial+meningitis+in+Blantyre,+Malawi&amp;author=EM+Molyneux&amp;author=M+Tembo&amp;author=K+Kayira&amp;author=L+Bwanaisa&amp;author=J+Mweneychanya&amp;volume=88&amp;publication_year=2003&amp;pages=1112-1118&amp;pmid=14670782&amp;doi=10.1136/adc.88.12.1112&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">The National Institutes of Health, University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia  Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. <span><span class="ref-journal">N Engl J Med. </span>1990;<span class="ref-vol">323</span>:1500\xe2\x80\x931504. doi: 10.1056/NEJM199011223232131.</span> [<a href="/pubmed/2136587" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJM199011223232131" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Consensus+statement+on+the+use+of+corticosteroids+as+adjunctive+therapy+for+Pneumocystis+pneumonia+in+the+acquired+immunodeficiency+syndrome&amp;volume=323&amp;publication_year=1990&amp;pages=1500-1504&amp;pmid=2136587&amp;doi=10.1056/NEJM199011223232131&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Bozzette SA, Sattler FR, Chiu J, for the California Collaborative Treatment Group et al.  A controlled trial of early adjunctive treatment with corticosteroids for <em>Pneumocystis carinii</em> pneumonia in the acquired immunodeficiency syndrome. <span><span class="ref-journal">N Engl J Med. </span>1990;<span class="ref-vol">323</span>:1451\xe2\x80\x931457. doi: 10.1056/NEJM199011223232104.</span> [<a href="/pubmed/2233917" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJM199011223232104" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+controlled+trial+of+early+adjunctive+treatment+with+corticosteroids+for+Pneumocystis+carinii+pneumonia+in+the+acquired+immunodeficiency+syndrome&amp;author=SA+Bozzette&amp;author=FR+Sattler&amp;author=J+Chiu&amp;volume=323&amp;publication_year=1990&amp;pages=1451-1457&amp;pmid=2233917&amp;doi=10.1056/NEJM199011223232104&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Montaner JSG, Lawson LM, Levitt N, Belzberg A, Schechter MT, Ruedy J. Corticosteroids prevent early deterioration in patients with moderately severe <em>Pneumocystis carinii</em> pneumonia and the acquired immunodeficiency syndrome (AIDS) <span><span class="ref-journal">Ann Intern Med. </span>1990;<span class="ref-vol">113</span>:14\xe2\x80\x9320. doi: 10.7326/0003-4819-113-1-14.</span> [<a href="/pubmed/2190515" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.7326%2F0003-4819-113-1-14" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Corticosteroids+prevent+early+deterioration+in+patients+with+moderately+severe+Pneumocystis+carinii+pneumonia+and+the+acquired+immunodeficiency+syndrome+(AIDS)&amp;author=JSG+Montaner&amp;author=LM+Lawson&amp;author=N+Levitt&amp;author=A+Belzberg&amp;author=MT+Schechter&amp;volume=113&amp;publication_year=1990&amp;pages=14-20&amp;pmid=2190515&amp;doi=10.7326/0003-4819-113-1-14&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Gagnon S, Boota M, Fisch M, Baier H, Kirksey OW, La Voie L. Corticosteroids as adjunctive therapy for severe <em>Pneumocystis carinii</em> pneumonia in the acquired immunodeficiency syndrome. <span><span class="ref-journal">N Engl J Med. </span>1990;<span class="ref-vol">323</span>:1444\xe2\x80\x931450. doi: 10.1056/NEJM199011223232103.</span> [<a href="/pubmed/2233916" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJM199011223232103" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Corticosteroids+as+adjunctive+therapy+for+severe+Pneumocystis+carinii+pneumonia+in+the+acquired+immunodeficiency+syndrome&amp;author=S+Gagnon&amp;author=M+Boota&amp;author=M+Fisch&amp;author=H+Baier&amp;author=OW+Kirksey&amp;volume=323&amp;publication_year=1990&amp;pages=1444-1450&amp;pmid=2233916&amp;doi=10.1056/NEJM199011223232103&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Walmsley S, Levinton C, Brunton J, Muradali D, Rappaport D, Bast M, Spence D, Salit I. A multicentre randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of <em>Pneumocystis carinii</em> pneumonia complicating the acquired immune deficiency syndrome. <span><span class="ref-journal">J Acq Immun Defic Syndr Hum Retrovirol. </span>1995;<span class="ref-vol">8</span>:348\xe2\x80\x93357.</span> [<a href="/pubmed/7882099" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Acq+Immun+Defic+Syndr+Hum+Retrovirol&amp;title=A+multicentre+randomized+double-blind+placebo-controlled+trial+of+adjunctive+corticosteroids+in+the+treatment+of+Pneumocystis+carinii+pneumonia+complicating+the+acquired+immune+deficiency+syndrome&amp;author=S+Walmsley&amp;author=C+Levinton&amp;author=J+Brunton&amp;author=D+Muradali&amp;author=D+Rappaport&amp;volume=8&amp;publication_year=1995&amp;pages=348-357&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Bozette SA, Morton SC. Reconsidering the use of adjunctive corticosteroids in <em>Pneumocystis</em> pneumonia. <span><span class="ref-journal">J Acq Immun Defic Syndr Hum Retrovirol. </span>1995;<span class="ref-vol">8</span>:345\xe2\x80\x93347.</span> [<a href="/pubmed/7882098" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Acq+Immun+Defic+Syndr+Hum+Retrovirol&amp;title=Reconsidering+the+use+of+adjunctive+corticosteroids+in+Pneumocystis+pneumonia&amp;author=SA+Bozette&amp;author=SC+Morton&amp;volume=8&amp;publication_year=1995&amp;pages=345-347&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della Porta R, Giorgio C, Blasi F, Umberger R, Meduri GU. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2005;<span class="ref-vol">171</span>:242\xe2\x80\x93248. doi: 10.1164/rccm.200406-808OC.</span> [<a href="/pubmed/15557131" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200406-808OC" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Hydrocortisone+infusion+for+severe+community-acquired+pneumonia:+a+preliminary+randomized+study&amp;author=M+Confalonieri&amp;author=R+Urbino&amp;author=A+Potena&amp;author=M+Piattella&amp;author=P+Parigi&amp;volume=171&amp;publication_year=2005&amp;pages=242-248&amp;pmid=15557131&amp;doi=10.1164/rccm.200406-808OC&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Ho JC, Ooi GC, Mok TY, Chan JW, Hung I, Lam B, Wong PC, Li PC, Ho PL, Lam WK, Ng CK, Ip MS, Lai KN, Chan-Yeung M, Tsang KW. High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2003;<span class="ref-vol">168</span>:1449\xe2\x80\x931456. doi: 10.1164/rccm.200306-766OC.</span> [<a href="/pubmed/12947028" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200306-766OC" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=High-dose+pulse+versus+nonpulse+corticosteroid+regimens+in+severe+acute+respiratory+syndrome&amp;author=JC+Ho&amp;author=GC+Ooi&amp;author=TY+Mok&amp;author=JW+Chan&amp;author=I+Hung&amp;volume=168&amp;publication_year=2003&amp;pages=1449-1456&amp;pmid=12947028&amp;doi=10.1164/rccm.200306-766OC&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Auyeung TW, Lee JS, Lai WK, Choi CH, Lee HK, Lee JS, Li PC, Lok KH, Ng YY, Wong WM, Yeung YM. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. <span><span class="ref-journal">J Infect. </span>2005;<span class="ref-vol">51</span>:98\xe2\x80\x93102. doi: 10.1016/j.jinf.2004.09.008.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7132384/">PMC free article</a>]</span> [<a href="/pubmed/16038758" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jinf.2004.09.008" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect&amp;title=The+use+of+corticosteroid+as+treatment+in+SARS+was+associated+with+adverse+outcomes:+a+retrospective+cohort+study&amp;author=TW+Auyeung&amp;author=JS+Lee&amp;author=WK+Lai&amp;author=CH+Choi&amp;author=HK+Lee&amp;volume=51&amp;publication_year=2005&amp;pages=98-102&amp;pmid=16038758&amp;doi=10.1016/j.jinf.2004.09.008&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Davison C, Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. <span><span class="ref-journal">Pediatr Crit Care Med. </span>2004;<span class="ref-vol">5</span>:482\xe2\x80\x93489. doi: 10.1097/01.PCC.0000128891.54799.67.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3867796/">PMC free article</a>]</span> [<a href="/pubmed/15329166" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F01.PCC.0000128891.54799.67" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Crit+Care+Med&amp;title=Efficacy+of+interventions+for+bronchiolitis+in+critically+ill+infants:+a+systematic+review+and+meta-analysis&amp;author=C+Davison&amp;author=KM+Ventre&amp;author=M+Luchetti&amp;author=AG+Randolph&amp;volume=5&amp;publication_year=2004&amp;pages=482-489&amp;pmid=15329166&amp;doi=10.1097/01.PCC.0000128891.54799.67&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Garrison MM, Christakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. <span><span class="ref-journal">Pediatrics. </span>2000;<span class="ref-vol">105</span>:44\xe2\x80\x9350. doi: 10.1542/peds.105.4.e44.</span> [<a href="/pubmed/10742365" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1542%2Fpeds.105.4.e44" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics&amp;title=Systemic+corticosteroids+in+infant+bronchiolitis:+a+meta-analysis&amp;author=MM+Garrison&amp;author=DA+Christakis&amp;author=E+Harvey&amp;author=P+Cummings&amp;author=RL+Davis&amp;volume=105&amp;publication_year=2000&amp;pages=44-50&amp;doi=10.1542/peds.105.4.e44&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Schuh S, Coates AL, Binnie R, Allin T, Goia C, Corey M, Dick PT. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. <span><span class="ref-journal">J Pediatr. </span>2002;<span class="ref-vol">140</span>:27\xe2\x80\x9332. doi: 10.1067/mpd.2002.120271.</span> [<a href="/pubmed/11815760" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1067%2Fmpd.2002.120271" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr&amp;title=Efficacy+of+oral+dexamethasone+in+outpatients+with+acute+bronchiolitis&amp;author=S+Schuh&amp;author=AL+Coates&amp;author=R+Binnie&amp;author=T+Allin&amp;author=C+Goia&amp;volume=140&amp;publication_year=2002&amp;pages=27-32&amp;pmid=11815760&amp;doi=10.1067/mpd.2002.120271&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Csonka P, Kaila M, Laippalla P, Iso-Mustajarvi M, Vesikari T, Ashorn P. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection induced lower airway disease: a randomized placebo-controlled trial. <span><span class="ref-journal">J Pediatr. </span>2003;<span class="ref-vol">143</span>:725\xe2\x80\x93730. doi: 10.1067/S0022-3476(03)00498-0.</span> [<a href="/pubmed/14657816" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1067%2FS0022-3476(03)00498-0" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr&amp;title=Oral+prednisolone+in+the+acute+management+of+children+age+6+to+35+months+with+viral+respiratory+infection+induced+lower+airway+disease:+a+randomized+placebo-controlled+trial&amp;author=P+Csonka&amp;author=M+Kaila&amp;author=P+Laippalla&amp;author=M+Iso-Mustajarvi&amp;author=T+Vesikari&amp;volume=143&amp;publication_year=2003&amp;pages=725-730&amp;pmid=14657816&amp;doi=10.1067/S0022-3476(03)00498-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Cade A, Brownlee KG, Conway SP, Haigh D, Short A, Brown J, Dassu D, Mason SA, Phillips A, Eglin R, et al.  Randomised placebo controlled trial of nebulised cotricosteroids in acute respiratory syncytial viral bronchiolitis. <span><span class="ref-journal">Arch Dis Child. </span>2000;<span class="ref-vol">82</span>:126\xe2\x80\x93130. doi: 10.1136/adc.82.2.126.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1718208/">PMC free article</a>]</span> [<a href="/pubmed/10648365" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fadc.82.2.126" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Dis+Child&amp;title=Randomised+placebo+controlled+trial+of+nebulised+cotricosteroids+in+acute+respiratory+syncytial+viral+bronchiolitis&amp;author=A+Cade&amp;author=KG+Brownlee&amp;author=SP+Conway&amp;author=D+Haigh&amp;author=A+Short&amp;volume=82&amp;publication_year=2000&amp;pages=126-130&amp;pmid=10648365&amp;doi=10.1136/adc.82.2.126&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. <span><span class="ref-journal">J Pediatr. </span>1998;<span class="ref-vol">132</span>:849\xe2\x80\x93853. doi: 10.1016/S0022-3476(98)70316-6.</span> [<a href="/pubmed/9602198" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0022-3476(98)70316-6" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr&amp;title=Early+nebulized+budesonide+in+the+treatment+of+bronchiolitis+and+the+prevention+of+postbronchiolitic+wheezing&amp;author=H+Richter&amp;author=P+Seddon&amp;volume=132&amp;publication_year=1998&amp;pages=849-853&amp;pmid=9602198&amp;doi=10.1016/S0022-3476(98)70316-6&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Fox FG, Everard ML, Marsh MJ, Milner AD. Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. <span><span class="ref-journal">Arch Dis Child. </span>1999;<span class="ref-vol">80</span>:343\xe2\x80\x93344. doi: 10.1136/adc.80.4.343.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1717884/">PMC free article</a>]</span> [<a href="/pubmed/10086941" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fadc.80.4.343" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Dis+Child&amp;title=Randomised+controlled+trial+of+budesonide+for+the+prevention+of+post-bronchiolitis+wheezing&amp;author=FG+Fox&amp;author=ML+Everard&amp;author=MJ+Marsh&amp;author=AD+Milner&amp;volume=80&amp;publication_year=1999&amp;pages=343-344&amp;pmid=10086941&amp;doi=10.1136/adc.80.4.343&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">McKean M, Ducharme F.  <span class="ref-journal">Inhaled steroids for episodic viral wheeze of childhood.</span> 2000.  [<a href="/pubmed/10796596" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Inhaled+steroids+for+episodic+viral+wheeze+of+childhood&amp;author=M+McKean&amp;author=F+Ducharme&amp;publication_year=2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Russell K, Wiebe N, Saenz A, Ausejo SM, Johnson D, Hartling L, Klassen TP.  <span class="ref-journal">Glucocorticoids for croup.</span> 2004.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Glucocorticoids+for+croup&amp;author=K+Russell&amp;author=N+Wiebe&amp;author=A+Saenz&amp;author=SM+Ausejo&amp;author=D+Johnson&amp;publication_year=2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Prasad K, Volmink J, Menon GR.  <span class="ref-journal">Steroids for treating tuberculous meningitis.</span> 2000.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Steroids+for+treating+tuberculous+meningitis&amp;author=K+Prasad&amp;author=J+Volmink&amp;author=GR+Menon&amp;publication_year=2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, Nguyen QH, Nguyen TT, Nguyen NH, Nguyen TN, et al.  Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. <span><span class="ref-journal">N Engl J Med. </span>2004;<span class="ref-vol">351</span>:1741\xe2\x80\x931752. doi: 10.1056/NEJMoa040573.</span> [<a href="/pubmed/15496623" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa040573" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Dexamethasone+for+the+treatment+of+tuberculous+meningitis+in+adolescents+and+adults&amp;author=GE+Thwaites&amp;author=DB+Nguyen&amp;author=HD+Nguyen&amp;author=TQ+Hoang&amp;author=TT+Do&amp;volume=351&amp;publication_year=2004&amp;pages=1741-1752&amp;pmid=15496623&amp;doi=10.1056/NEJMoa040573&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Quagliarello V. Adjunctive steroids for tuberculous meningitis &#x02013; more evidence, more questions. <span><span class="ref-journal">N Engl J Med. </span>2004;<span class="ref-vol">351</span>:1792\xe2\x80\x931795. doi: 10.1056/NEJMe048223.</span> [<a href="/pubmed/15496631" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMe048223" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Adjunctive+steroids+for+tuberculous+meningitis+&#x02013;+more+evidence,+more+questions&amp;author=V+Quagliarello&amp;volume=351&amp;publication_year=2004&amp;pages=1792-1795&amp;pmid=15496631&amp;doi=10.1056/NEJMe048223&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="element-citation">Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ.  <span class="ref-journal">Interventions for treating tuberculous pericarditis.</span> 2002.  [<a href="/pubmed/12519546" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Interventions+for+treating+tuberculous+pericarditis&amp;author=BM+Mayosi&amp;author=M+Ntsekhe&amp;author=JA+Volmink&amp;author=PJ+Commerford&amp;publication_year=2002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Strang JIG, Nunn AJ, Johnson DA, Casbard A, Gibson DG, Girling DJ. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. <span><span class="ref-journal">Quart J Med. </span>2004;<span class="ref-vol">97</span>:525\xe2\x80\x93535. doi: 10.1093/qjmed/hch086.</span> [<a href="/pubmed/15256610" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fqjmed%2Fhch086" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Quart+J+Med&amp;title=Management+of+tuberculous+constrictive+pericarditis+and+tuberculous+pericardial+effusion+in+Transkei:+results+at+10+years+follow-up&amp;author=JIG+Strang&amp;author=AJ+Nunn&amp;author=DA+Johnson&amp;author=A+Casbard&amp;author=DG+Gibson&amp;volume=97&amp;publication_year=2004&amp;pages=525-535&amp;doi=10.1093/qjmed/hch086&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Matchaba PT, Volmink J.  <span class="ref-journal">Steroids for treating tuberculous pleurisy.</span> 2000.  [<a href="/pubmed/10796669" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Steroids+for+treating+tuberculous+pleurisy&amp;author=PT+Matchaba&amp;author=J+Volmink&amp;publication_year=2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="element-citation">Elliott AM, Luzze H, Quigley MA, Nakiyingi JS, Kyaligonza S, Namujju PB, Ducar C, Ellner JJ, Whitworth JAG, Mugerwa R, et al.  A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. <span><span class="ref-journal">J Infect Dis. </span>2004;<span class="ref-vol">190</span>:869\xe2\x80\x93878. doi: 10.1086/422257.</span> [<a href="/pubmed/15295690" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F422257" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=A+randomized,+double-blind,+placebo-controlled+trial+of+the+use+of+prednisolone+as+an+adjunct+to+treatment+in+HIV-1-associated+pleural+tuberculosis&amp;author=AM+Elliott&amp;author=H+Luzze&amp;author=MA+Quigley&amp;author=JS+Nakiyingi&amp;author=S+Kyaligonza&amp;volume=190&amp;publication_year=2004&amp;pages=869-878&amp;pmid=15295690&amp;doi=10.1086/422257&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR45">45. <span class="element-citation">Smego RA, Ahmed N. A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis. <span><span class="ref-journal">Intl J Tuberculosis and Lung Dis. </span>2002;<span class="ref-vol">7</span>:208\xe2\x80\x93213.</span> [<a href="/pubmed/12661833" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Intl+J+Tuberculosis+and+Lung+Dis&amp;title=A+systematic+review+of+the+adjunctive+use+of+systemic+corticosteroids+for+pulmonary+tuberculosis&amp;author=RA+Smego&amp;author=N+Ahmed&amp;volume=7&amp;publication_year=2002&amp;pages=208-213&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR46">46. <span class="element-citation">Nemir RL, Cardona J, Vaziri F, Toledo R. Prednisone as an adjunct chemotherapy of lymph node bronchial tuberulosis in childhood: a double blind study. <span><span class="ref-journal">Am Rev Respir Dis. </span>1967;<span class="ref-vol">5</span>:402\xe2\x80\x93410.</span> [<a href="/pubmed/5335164" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+Rev+Respir+Dis&amp;title=Prednisone+as+an+adjunct+chemotherapy+of+lymph+node+bronchial+tuberulosis+in+childhood:+a+double+blind+study&amp;author=RL+Nemir&amp;author=J+Cardona&amp;author=F+Vaziri&amp;author=R+Toledo&amp;volume=5&amp;publication_year=1967&amp;pages=402-410&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR47">47. <span class="element-citation">Toppet M, Malfroot A, Derde MP, Toppet T, Dab I. Corticosteroids in primary tuberculosis with bronchial obstruction. <span><span class="ref-journal">Arch Dis Child. </span>1990;<span class="ref-vol">65</span>:1222\xe2\x80\x931226. doi: 10.1136/adc.65.11.1222.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1792610/">PMC free article</a>]</span> [<a href="/pubmed/2248533" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fadc.65.11.1222" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Dis+Child&amp;title=Corticosteroids+in+primary+tuberculosis+with+bronchial+obstruction&amp;author=M+Toppet&amp;author=A+Malfroot&amp;author=MP+Derde&amp;author=T+Toppet&amp;author=I+Dab&amp;volume=65&amp;publication_year=1990&amp;pages=1222-1226&amp;pmid=2248533&amp;doi=10.1136/adc.65.11.1222&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR48">48. <span class="element-citation">Mayanja-Kizza H, Jones-Lopez E, Okwera A, Wallis RS, Ellner JJ, Mugerwa RD, Whalen CC, Uganda-Case Western Research Collaboration  Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. <span><span class="ref-journal">J Infect Dis. </span>2005;<span class="ref-vol">191</span>:856\xe2\x80\x93865. doi: 10.1086/427995.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4515766/">PMC free article</a>]</span> [<a href="/pubmed/15717259" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F427995" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Immunoadjuvant+prednisolone+therapy+for+HIV-associated+tuberculosis:+a+phase+2+clinical+trial+in+Uganda&amp;author=H+Mayanja-Kizza&amp;author=E+Jones-Lopez&amp;author=A+Okwera&amp;author=RS+Wallis&amp;author=JJ+Ellner&amp;volume=191&amp;publication_year=2005&amp;pages=856-865&amp;pmid=15717259&amp;doi=10.1086/427995&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR49">49. <span class="element-citation">Wood-Baker RR, Gibson PG, Hannay M, Walters EH, Walters JAE.  <span class="ref-journal">Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.</span> 2005.  [<a href="/pubmed/15674875" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Systemic+corticosteroids+for+acute+exacerbations+of+chronic+obstructive+pulmonary+disease&amp;author=RR+Wood-Baker&amp;author=PG+Gibson&amp;author=M+Hannay&amp;author=EH+Walters&amp;author=JAE+Walters&amp;publication_year=2005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR50">50. <span class="element-citation">Singh JM, Palda VA, Stanbrook MB, Chapman KR. Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease. <span><span class="ref-journal">Arch Intern Med. </span>2002;<span class="ref-vol">162</span>:2527\xe2\x80\x932536. doi: 10.1001/archinte.162.22.2527.</span> [<a href="/pubmed/12456224" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1001%2Farchinte.162.22.2527" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Intern+Med&amp;title=Corticosteroid+therapy+for+patients+with+acute+exacerbations+of+chronic+obstructive+pulmonary+disease&amp;author=JM+Singh&amp;author=VA+Palda&amp;author=MB+Stanbrook&amp;author=KR+Chapman&amp;volume=162&amp;publication_year=2002&amp;pages=2527-2536&amp;pmid=12456224&amp;doi=10.1001/archinte.162.22.2527&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR51">51. <span class="element-citation">Sin DD, McAlister FA, Man SFP, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. <span><span class="ref-journal">J Am Med Assoc. </span>2003;<span class="ref-vol">290</span>:2301\xe2\x80\x932312. doi: 10.1001/jama.290.17.2301.</span> [<a href="/pubmed/14600189" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1001%2Fjama.290.17.2301" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Med+Assoc&amp;title=Contemporary+management+of+chronic+obstructive+pulmonary+disease:+scientific+review&amp;author=DD+Sin&amp;author=FA+McAlister&amp;author=SFP+Man&amp;author=NR+Anthonisen&amp;volume=290&amp;publication_year=2003&amp;pages=2301-2312&amp;doi=10.1001/jama.290.17.2301&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR52">52. <span class="element-citation">Balfour-Lynn I, Walters S, Dezateux C.  <span class="ref-journal">Inhaled corticosteroids for cystic fibrosis.</span> 2000.  [<a href="/pubmed/10796838" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Inhaled+corticosteroids+for+cystic+fibrosis&amp;author=I+Balfour-Lynn&amp;author=S+Walters&amp;author=C+Dezateux&amp;publication_year=2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR53">53. <span class="element-citation">Mellerup MT, Krogsgaard K, Mathurin P, Gluud C, Poynard T.  <span class="ref-journal">Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B.</span> 2002.  [<a href="/pubmed/12076393" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Sequential+combination+of+glucocorticosteroids+and+alfa+interferon+versus+alfa+interferon+alone+for+HBeAg-positive+chronic+hepatitis+B&amp;author=MT+Mellerup&amp;author=K+Krogsgaard&amp;author=P+Mathurin&amp;author=C+Gluud&amp;author=T+Poynard&amp;publication_year=2002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR54">54. <span class="element-citation">Brok J, Mellerup MT, Krogsgaard K, Gluud C.  <span class="ref-journal">Glucocorticosteroids for viral hepatitis C.</span> 2004.  [<a href="/pubmed/15106184" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Glucocorticosteroids+for+viral+hepatitis+C&amp;author=J+Brok&amp;author=MT+Mellerup&amp;author=K+Krogsgaard&amp;author=C+Gluud&amp;publication_year=2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR55">55. <span class="element-citation">Gregory PB, Knauer M, Kempson RL, Miller R. Steroid therapy for viral hepatitis. <span><span class="ref-journal">N Engl J Med. </span>1976;<span class="ref-vol">294</span>:681\xe2\x80\x93687. doi: 10.1056/NEJM197603252941301.</span> [<a href="/pubmed/765822" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJM197603252941301" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Steroid+therapy+for+viral+hepatitis&amp;author=PB+Gregory&amp;author=M+Knauer&amp;author=RL+Kempson&amp;author=R+Miller&amp;volume=294&amp;publication_year=1976&amp;pages=681-687&amp;pmid=765822&amp;doi=10.1056/NEJM197603252941301&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR56">56. <span class="element-citation">Salinas RA, Alvarez G, Ferreira J.  <span class="ref-journal">Corticosteroids for Bell\'s palsy (idiopathic facial paralysis)</span> 2004.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Corticosteroids+for+Bell\'s+palsy+(idiopathic+facial+paralysis)&amp;author=RA+Salinas&amp;author=G+Alvarez&amp;author=J+Ferreira&amp;publication_year=2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR57">57. <span class="element-citation">Prasad K, Garner P.  <span class="ref-journal">Steroids for treating cerebral malaria.</span> 1999.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Steroids+for+treating+cerebral+malaria&amp;author=K+Prasad&amp;author=P+Garner&amp;publication_year=1999&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR58">58. <span class="element-citation">Warrell DA, Looareesuwan S, Warrell MJ, Kasemsarn P, Intaraprasert R, Bunnag D, Harinasuta T. Dexamethasone proves deleterious in cerebral malaria: a double blind trial in 100 comatose patients. <span><span class="ref-journal">N Engl J Med. </span>1982;<span class="ref-vol">306</span>:313\xe2\x80\x93319. doi: 10.1056/NEJM198202113060601.</span> [<a href="/pubmed/7033788" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJM198202113060601" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Dexamethasone+proves+deleterious+in+cerebral+malaria:+a+double+blind+trial+in+100+comatose+patients&amp;author=DA+Warrell&amp;author=S+Looareesuwan&amp;author=MJ+Warrell&amp;author=P+Kasemsarn&amp;author=R+Intaraprasert&amp;volume=306&amp;publication_year=1982&amp;pages=313-319&amp;pmid=7033788&amp;doi=10.1056/NEJM198202113060601&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR59">59. <span class="element-citation">Adeniyi A, Hendrickse RG. Selectivity of proteinuria and response to prednisolone or immunosuppressive drugs in children with malarial nephrosis. <span><span class="ref-journal">Lancet. </span>1970;<span class="ref-vol">i</span>:644\xe2\x80\x93648. doi: 10.1016/S0140-6736(70)90885-8.</span> [<a href="/pubmed/4190632" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(70)90885-8" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Selectivity+of+proteinuria+and+response+to+prednisolone+or+immunosuppressive+drugs+in+children+with+malarial+nephrosis&amp;author=A+Adeniyi&amp;author=RG+Hendrickse&amp;volume=i&amp;publication_year=1970&amp;pages=644-648&amp;doi=10.1016/S0140-6736(70)90885-8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR60">60. <span class="element-citation">Rogerson SJ, Spooner VJ, Smith TA, Richens J. Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New Guinea. <span><span class="ref-journal">Trans Roy Soc Trop Med Hygiene. </span>1991;<span class="ref-vol">85</span>:113\xe2\x80\x93116. doi: 10.1016/0035-9203(91)90180-7.</span> [<a href="/pubmed/2068737" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0035-9203(91)90180-7" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trans+Roy+Soc+Trop+Med+Hygiene&amp;title=Hydrocortisone+in+chloramphenicol-treated+severe+typhoid+fever+in+Papua+New+Guinea&amp;author=SJ+Rogerson&amp;author=VJ+Spooner&amp;author=TA+Smith&amp;author=J+Richens&amp;volume=85&amp;publication_year=1991&amp;pages=113-116&amp;doi=10.1016/0035-9203(91)90180-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR61">61. <span class="element-citation">Hoffman SL, Punjabi NH, Kumala S, Moechtar MA, Pulungsih SP, Rivai AR, Rockhill RC, Woodward TE, Loedin AA. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high dose dexamethasone. <span><span class="ref-journal">N Engl J Med. </span>1984;<span class="ref-vol">310</span>:282\xe2\x80\x93288.</span> [<a href="/pubmed/6361558" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Reduction+of+mortality+in+chloramphenicol-treated+severe+typhoid+fever+by+high+dose+dexamethasone&amp;author=SL+Hoffman&amp;author=NH+Punjabi&amp;author=S+Kumala&amp;author=MA+Moechtar&amp;author=SP+Pulungsih&amp;volume=310&amp;publication_year=1984&amp;pages=282-288&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR62">62. <span class="element-citation">Punjabi NH, Hoffman SL, Edman DC, Sukri N, Laughlin LW, Pulungsih SP, Rivai AR, Sututo, Moechtar A, Woodward TE. Treatment of severe typhoid fever in children with high dose dexamethasone. <span><span class="ref-journal">Pediatr Infect Dis J. </span>1988;<span class="ref-vol">7</span>:598\xe2\x80\x93600. doi: 10.1097/00006454-198808000-00002.</span> [<a href="/pubmed/3050856" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F00006454-198808000-00002" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Infect+Dis+J&amp;title=Treatment+of+severe+typhoid+fever+in+children+with+high+dose+dexamethasone&amp;author=NH+Punjabi&amp;author=SL+Hoffman&amp;author=DC+Edman&amp;author=N+Sukri&amp;author=LW+Laughlin&amp;volume=7&amp;publication_year=1988&amp;pages=598-600&amp;pmid=3050856&amp;doi=10.1097/00006454-198808000-00002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR63">63. <span class="element-citation">Ajao OG, Ajao A, Johnson T. Methylprednisolone sodium succinate (solumedrol) in the treatment of typhoid perforation (a preliminary report) <span><span class="ref-journal">Trans Roy Soc Trop Med Hygiene. </span>1984;<span class="ref-vol">78</span>:573\xe2\x80\x93576. doi: 10.1016/0035-9203(84)90207-4.</span> [<a href="/pubmed/6390802" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0035-9203(84)90207-4" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trans+Roy+Soc+Trop+Med+Hygiene&amp;title=Methylprednisolone+sodium+succinate+(solumedrol)+in+the+treatment+of+typhoid+perforation+(a+preliminary+report)&amp;author=OG+Ajao&amp;author=A+Ajao&amp;author=T+Johnson&amp;volume=78&amp;publication_year=1984&amp;pages=573-576&amp;doi=10.1016/0035-9203(84)90207-4&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR64">64. <span class="element-citation">Odio CM, Ramirez T, Arias G, Abdelnour A, Hidalgo I, Herrera ML, Bolanos W, Alpizar J, Alvarez P. Double-blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children. <span><span class="ref-journal">Pediatr Infect Dis J. </span>2003;<span class="ref-vol">22</span>:883\xe2\x80\x93888. doi: 10.1097/01.inf.0000091293.32187.7b.</span> [<a href="/pubmed/14551489" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F01.inf.0000091293.32187.7b" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Infect+Dis+J&amp;title=Double-blind,+randomized,+placebo-controlled+study+of+dexamethasone+therapy+for+hematogenous+septic+arthritis+in+children&amp;author=CM+Odio&amp;author=T+Ramirez&amp;author=G+Arias&amp;author=A+Abdelnour&amp;author=I+Hidalgo&amp;volume=22&amp;publication_year=2003&amp;pages=883-888&amp;pmid=14551489&amp;doi=10.1097/01.inf.0000091293.32187.7b&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR65">65. <span class="element-citation">Min M, Aye M, Shwe T, Swe T, Aye B. Hydrodcortisone in the management of dengue shock syndrome. <span><span class="ref-journal">SE Asian J Trop Med Public Health. </span>1975;<span class="ref-vol">6</span>:573\xe2\x80\x93579.</span> [<a href="/pubmed/131976" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=SE+Asian+J+Trop+Med+Public+Health&amp;title=Hydrodcortisone+in+the+management+of+dengue+shock+syndrome&amp;author=M+Min&amp;author=M+Aye&amp;author=T+Shwe&amp;author=T+Swe&amp;author=B+Aye&amp;volume=6&amp;publication_year=1975&amp;pages=573-579&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR66">66. <span class="element-citation">Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S. Failure of high dose methylprednisolone in established dengue shock syndrome: a placebo controlled, double blind study. <span><span class="ref-journal">Pediatrics. </span>1993;<span class="ref-vol">92</span>:111\xe2\x80\x93113.</span> [<a href="/pubmed/8516054" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics&amp;title=Failure+of+high+dose+methylprednisolone+in+established+dengue+shock+syndrome:+a+placebo+controlled,+double+blind+study&amp;author=S+Tassniyom&amp;author=S+Vasanawathana&amp;author=A+Chirawatkul&amp;author=S+Rojanasuphot&amp;volume=92&amp;publication_year=1993&amp;pages=111-113&amp;pmid=8516054&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR67">67. <span class="element-citation">Sumarmo, Talogo W, Asrin A, Isnuhandojo B, Sahudi A. Failure of hydrocortisone to affect outcome in dengue shock syndrome. <span><span class="ref-journal">Pediatrics. </span>1982;<span class="ref-vol">69</span>:45\xe2\x80\x9349.</span> [<a href="/pubmed/7054760" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics&amp;title=Failure+of+hydrocortisone+to+affect+outcome+in+dengue+shock+syndrome&amp;author=+Sumarmo&amp;author=W+Talogo&amp;author=A+Asrin&amp;author=B+Isnuhandojo&amp;author=A+Sahudi&amp;volume=69&amp;publication_year=1982&amp;pages=45-49&amp;pmid=7054760&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR68">68. <span class="element-citation">Roy M, Bailey B, Amre DK, Girodias JB, Bussieres JF, Gaudreault P. Dexamethasone for the treatment of sore throat in children with suspected infectious mononucleosis: a randomized, double-blind, placebo-controlled clinical trial. <span><span class="ref-journal">Arch Paed Adolesc Med. </span>2004;<span class="ref-vol">158</span>:250\xe2\x80\x93254. doi: 10.1001/archpedi.158.3.250.</span> [<a href="/pubmed/14993084" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1001%2Farchpedi.158.3.250" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Paed+Adolesc+Med&amp;title=Dexamethasone+for+the+treatment+of+sore+throat+in+children+with+suspected+infectious+mononucleosis:+a+randomized,+double-blind,+placebo-controlled+clinical+trial&amp;author=M+Roy&amp;author=B+Bailey&amp;author=DK+Amre&amp;author=JB+Girodias&amp;author=JF+Bussieres&amp;volume=158&amp;publication_year=2004&amp;pages=250-254&amp;doi=10.1001/archpedi.158.3.250&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR69">69. <span class="element-citation">Tynell E, Aurelius E, Brandell A, Julander I, Wood M, Yao QY, Rickinson A, Akerlund B, Andersson J. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. <span><span class="ref-journal">J Infect Dis. </span>1996;<span class="ref-vol">174</span>:324\xe2\x80\x93331. doi: 10.1093/infdis/174.2.324.</span> [<a href="/pubmed/8699062" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Finfdis%2F174.2.324" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Acyclovir+and+prednisolone+treatment+of+acute+infectious+mononucleosis:+a+multicenter,+double-blind,+placebo-controlled+study&amp;author=E+Tynell&amp;author=E+Aurelius&amp;author=A+Brandell&amp;author=I+Julander&amp;author=M+Wood&amp;volume=174&amp;publication_year=1996&amp;pages=324-331&amp;pmid=8699062&amp;doi=10.1093/infdis/174.2.324&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR70">70. <span class="element-citation">Brandfonbrener A, Epstein A, Wu S, Phair J. Corticosteroid therapy in Epstein-Barr virus infection. Effect on lymphocyte class, subset, and response to early antigen. <span><span class="ref-journal">Arch Intern Med. </span>1986;<span class="ref-vol">146</span>:337\xe2\x80\x93339. doi: 10.1001/archinte.1986.00360140167024.</span> [<a href="/pubmed/3004369" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1001%2Farchinte.1986.00360140167024" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Intern+Med&amp;title=Corticosteroid+therapy+in+Epstein-Barr+virus+infection.+Effect+on+lymphocyte+class,+subset,+and+response+to+early+antigen&amp;author=A+Brandfonbrener&amp;author=A+Epstein&amp;author=S+Wu&amp;author=J+Phair&amp;volume=146&amp;publication_year=1986&amp;pages=337-339&amp;pmid=3004369&amp;doi=10.1001/archinte.1986.00360140167024&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR71">71. <span class="element-citation">Pillay V, Swingler G.  <span class="ref-journal">Symptomatic treatment of the cough in whooping cough.</span> 2003.  [<a href="/pubmed/14583962" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Symptomatic+treatment+of+the+cough+in+whooping+cough&amp;author=V+Pillay&amp;author=G+Swingler&amp;publication_year=2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR72">72. <span class="element-citation">WHO Expert Committee on Leprosy  . <span class="ref-journal">Seventh report. Technical Report Series, 874.</span> Geneva: Geneva; World Health Organization; 1998.  [<a href="/pubmed/9627517" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Seventh+report.+Technical+Report+Series,+874&amp;publication_year=1998&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR73">73. <span class="element-citation">Britton WJ. The management of leprosy reversal reactions. <span><span class="ref-journal">Leprosy Rev. </span>1998;<span class="ref-vol">69</span>:225\xe2\x80\x93234. doi: 10.5935/0305-7518.19980024.</span> [<a href="/pubmed/9805878" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.5935%2F0305-7518.19980024" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leprosy+Rev&amp;title=The+management+of+leprosy+reversal+reactions&amp;author=WJ+Britton&amp;volume=69&amp;publication_year=1998&amp;pages=225-234&amp;pmid=9805878&amp;doi=10.5935/0305-7518.19980024&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR74">74. <span class="element-citation">Smith WC, Anderson AM, Withington SG, van Brakel WH, Croft RP, Nicholls PG, Richardus JH. Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomized placebo controlled trial (Tripod 1) <span><span class="ref-journal">Br Med J. </span>2004;<span class="ref-vol">328</span>:1459\xe2\x80\x931462. doi: 10.1136/bmj.38107.645926.AE.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC428511/">PMC free article</a>]</span> [<a href="/pubmed/15159285" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fbmj.38107.645926.AE" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+Med+J&amp;title=Steroid+prophylaxis+for+prevention+of+nerve+function+impairment+in+leprosy:+randomized+placebo+controlled+trial+(Tripod+1)&amp;author=WC+Smith&amp;author=AM+Anderson&amp;author=SG+Withington&amp;author=WH+van+Brakel&amp;author=RP+Croft&amp;volume=328&amp;publication_year=2004&amp;pages=1459-1462&amp;pmid=15159285&amp;doi=10.1136/bmj.38107.645926.AE&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR75">75. <span class="element-citation">Richardus JH, Withington SG, Anderson AM, Croft RP, Nicholls PG, Van Brakel WH, Smith WC. Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (Tripod 3) <span><span class="ref-journal">Leprosy Rev. </span>2003;<span class="ref-vol">74</span>:311\xe2\x80\x93318.</span> [<a href="/pubmed/14750576" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leprosy+Rev&amp;title=Treatment+with+corticosteroids+of+long-standing+nerve+function+impairment+in+leprosy:+a+randomized+controlled+trial+(Tripod+3)&amp;author=JH+Richardus&amp;author=SG+Withington&amp;author=AM+Anderson&amp;author=RP+Croft&amp;author=PG+Nicholls&amp;volume=74&amp;publication_year=2003&amp;pages=311-318&amp;pmid=14750576&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR76">76. <span class="element-citation">Orme M, Breckenridge AM. The chemotherapy of onchocerciasis VII. <span><span class="ref-journal">Ann Trop Med Parasitol. </span>1982;<span class="ref-vol">76</span>:331\xe2\x80\x93338.</span> [<a href="/pubmed/6751250" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Trop+Med+Parasitol&amp;title=The+chemotherapy+of+onchocerciasis+VII&amp;author=M+Orme&amp;author=AM+Breckenridge&amp;volume=76&amp;publication_year=1982&amp;pages=331-338&amp;pmid=6751250&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR77">77. <span class="element-citation">Orme M, Breckenridge AM. The chemotherapy of onchocerciasis IX. <span><span class="ref-journal">Ann Trop Med Parasitol. </span>1982;<span class="ref-vol">76</span>:547\xe2\x80\x93555.</span> [<a href="/pubmed/6760823" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Trop+Med+Parasitol&amp;title=The+chemotherapy+of+onchocerciasis+IX&amp;author=M+Orme&amp;author=AM+Breckenridge&amp;volume=76&amp;publication_year=1982&amp;pages=547-555&amp;pmid=6760823&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR78">78. <span class="element-citation">Mall RK, Garg RK, Kar AM, Shuhkla R. Short course of prednisolone in indian patients with solitary cysticercus and new onset seizures. <span><span class="ref-journal">Epilepsia. </span>2003;<span class="ref-vol">44</span>:1397\xe2\x80\x931401. doi: 10.1046/j.1528-1157.2003.08003.x.</span> [<a href="/pubmed/14636346" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1046%2Fj.1528-1157.2003.08003.x" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;title=Short+course+of+prednisolone+in+indian+patients+with+solitary+cysticercus+and+new+onset+seizures&amp;author=RK+Mall&amp;author=RK+Garg&amp;author=AM+Kar&amp;author=R+Shuhkla&amp;volume=44&amp;publication_year=2003&amp;pages=1397-1401&amp;pmid=14636346&amp;doi=10.1046/j.1528-1157.2003.08003.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1550829&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1550829/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1550829/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1550829/pdf/13054_2005_Article_3820.pdf">PDF (175K)</a></li> | <li><a href="#" data-citationid="PMC1550829" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1550829%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1550829%2F&amp;text=Clinical%20review%3A%20A%20systematic%20review%20of%20corticosteroid%20use%20in%20infections"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1550829%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="16356204" data-aiid="7097749" data-aid="1550829" data-iid="354832" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC1550829" data-md5="81be5c21be74dd2922a5221e21890c52"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:18:37-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1BD914E99A95210000000002280228&amp;ncbi_session=8A1BD914E99ACAD1_0552SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1550829%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1550829/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1BD914E99ACAD1_0552SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'